Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SOX2 helps reduce wound size and pressure ulcer formation by suppressing oxidative stress and increasing antioxidant activity in mice.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Blocking certain proteins on immune cells may help treat alopecia areata.

SOX4 is crucial for the development of melanoma.

Atopic dermatitis shows a link between skin layers in inflammation, detectable with detailed gene analysis.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

A new test using NOS2 and CCL27 genes can better diagnose and treat psoriasis and eczema.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Interleukin 6 may help protect skin without causing inflammation.

Targeting the AhR pathway may help treat alopecia areata.

Hair follicles in mice help detect and respond to germs.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

FoxN1 overexpression in young mice harms immune cell and skin development.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Hair follicles help attract immune cells to the skin during stress.

Over-expression of Sp2 can lead to cancer by preventing proper stem cell differentiation.